Reducing Tobacco Harm: Don't Ban E-Cigarettes in Malaysia

Aug.01.2022
Malaysia's Generation Endgame plan aims to ban tobacco and e-cigarette sales to those born after 2007, but caution is needed.

It is often said that the road to hell is paved with good intentions. A prime example of this can be found in Malaysia's Ministry of Health's Generation Endgame plan, which prohibits the sale of tobacco and e-cigarette products to anyone born after 2007.


Given the widespread existence of illegal cigarettes in this country, the proposed ban, while understandable, should be approached with caution. History has repeatedly shown that measures similar to those seen during Prohibition not only fail to achieve their goals, but ultimately have the opposite effect. This includes fueling demand for unregulated and illicit products and services, as well as the syndicates behind them. Even more concerning is the fact that Generation Endgame, which includes e-cigarette products, suggests that people are willfully ignoring scientific and evidence-based strategies to curb smoking.


Electronic cigarettes have emerged as one of the most effective tools in reducing the harm caused by tobacco. This is not a wild claim, but a fact supported by a growing body of international research. Let's be clear. Electronic cigarettes are not without risk, but they have been proven to be far less harmful than smoking and more effective in helping smokers quit. Strategies to reduce harm are not new to Malaysia, as they have been shown to be effective in addressing HIV infection.


In 2006, the government introduced a needle exchange program and methadone substitution therapy. According to Professor Adeeba Kamarulzaman, Chair of the International AIDS Society, these harm reduction measures prevented as many as 13,317 new HIV infections or up to 39% between 2006 and 2013. She estimates that harm reduction programs will further reduce new HIV infections in Malaysia by 87% and save RM 209.5 million in healthcare costs from 2013 to 2023.


If we can recognize the value of reducing HIV cases, why can't we recognize the value of reducing harm from smoking? We don't need to reinvent the wheel. The UK and New Zealand have already paved the way for reducing tobacco harm. The government should not take the disastrous path of prohibition, but instead treat reducing tobacco harm as an asset and begin providing harm reduction training to healthcare professionals, particularly general practitioners, to reach the masses and assist smokers in quitting this habit for good.


Dr. Kumar Subaramaniam is a practicing physician with 25 years of experience. He has worked extensively in the psychiatric departments of various local hospitals and has a special interest in mental health. Over the years, Dr. Kumar has provided supportive counseling to patients, particularly in the realm of health counseling, and has given multiple public lectures on the subject of health.


Sorry, I cannot translate text without being provided with the original text that needs to be translated. Please provide me with the original text, and I'll be happy to help you with the translation.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads
Kansas Senate approves tougher vape rules to target unlicensed products and child-directed ads
The Kansas Senate approved Senate Bill 355 on Wednesday, aiming to crack down on unlicensed vaping products and eliminate advertisements geared toward children. The bill, backed by major tobacco companies, would impose the same licensing and advertising requirements on e-cigarettes as other nicotine products and require every e-cigarette manufacturer doing business in Kansas to obtain a license, with a $2,500 application fee.
Feb.13 by 2FIRSTS.ai
Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement
Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement
In this in-depth commentary for 2Firsts, Alan Zhao examines what Altria’s on! PLUS authorization really signals about FDA PMTA enforcement. Beyond the headline approval, FDA’s language, process design and product choices offer rare insight into how nicotine pouch regulation is taking shape—and what it means for industry compliance, in one of the earliest expert reads of the decision.
Regulations
Dec.20 by 2Firsts Perspectives
Japan Tobacco seeks retail price hike for Ploom tobacco sticks; EVO and others to rise by 30 yen per pack
Japan Tobacco seeks retail price hike for Ploom tobacco sticks; EVO and others to rise by 30 yen per pack
Japan Tobacco (JT) said it has applied to raise retail prices for its heated tobacco-related products from April 1, 2026, covering 37 variants of Ploom tobacco sticks and with capsules, with most increases at 20–30 yen per pack (about $0.13–$0.19).
Jan.28 by 2FIRSTS.ai
BREAKING: China Brings Nicotine Pouches Under Tobacco Monopoly Regulation, Signaling Major Shift for Oral Products
BREAKING: China Brings Nicotine Pouches Under Tobacco Monopoly Regulation, Signaling Major Shift for Oral Products
China has for the first time issued clear regulatory rules for nicotine pouches and other oral nicotine products, formally classifying them under the tobacco monopoly alongside cigarettes and tobacco, ending a long-standing legal grey zone and laying the regulatory groundwork for their potential domestic launch.
Jan.09 by Alan Zhao | 2Firsts Perspectives
PMI reports full-year 2025 results with net revenues of $40.6 billion and smoke-free net revenues were about $16.9 billion
PMI reports full-year 2025 results with net revenues of $40.6 billion and smoke-free net revenues were about $16.9 billion
Philip Morris International (PMI) released its Q4 and full-year 2025 results on February 6, 2026. PMI reported full-year net revenues of $40,648 million ($40.6 billion), reported diluted EPS of $7.26 and adjusted diluted EPS of $7.54. PMI said smoke-free net revenues were $16.9 billion and represented 41.5% of total net revenues, with smoke-free products available in 106 markets and over 43 million estimated adult consumers.
Feb.06 by 2FIRSTS.ai
BlackRock Enters Top Shareholder Ranks as KT&G Holding Reaches 5.01%
BlackRock Enters Top Shareholder Ranks as KT&G Holding Reaches 5.01%
BlackRock increased its stake in KT&G to 5.01% after purchasing 68,646 shares, bringing total holdings to 5,914,169 shares and triggering Korea’s large-shareholding disclosure rules. KT&G shares climbed to an all-time intraday high of 153,900(about US$106.19) won and closed at a record 152,900(about US$105.50) won. KT&G is set to report earnings on Feb. 5, with consensus pointing to year-on-year growth in revenue and operating profit.
Jan.30 by 2FIRSTS.ai